Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and ?1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats
Authors:
- 31 July 2003
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 169 (3) , 247-256
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in miceJournal of Neural Transmission, 1999
- Systemic PCP treatment elevates brain extracellular 5-HTNeuroReport, 1998
- Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in RatsScience, 1998
- The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5‐hydroxytryptamine2A receptor antagonist, in ratsBritish Journal of Pharmacology, 1997
- NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy VolunteersNeuropsychopharmacology, 1996
- Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbensBrain Research, 1992
- Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the ratJournal of Comparative Neurology, 1992
- Phencyclidine increases extracellular dopamine metabolites in rat medial frontal cortex as measured by in vivo dialysisNeuroscience Letters, 1990
- Dopamine and the Pathophysiology of Dyskinesias Induced by Antipsychotic DrugsAnnual Review of Neuroscience, 1980
- Amphetamine psychosis: Behavioral and biochemical aspectsJournal of Psychiatric Research, 1974